---
title: Biotech and Pharma best performers w/e 10/18
description: best performing biotech stocks to end 18 October 2024
---

[Skip to content](https://info.mtmresearch.com/blog/biotech-and-pharma-best-performers-w/e-10/18#main-content)

[![MTM Data Research Logo](https://info.mtmresearch.com/hs-fs/hubfs/logo-blue-1-svg.png?width=200&height=43&name=logo-blue-1-svg.png)](https://info.mtmresearch.com/blog)

- [Blog](https://info.mtmresearch.com/blog)
- [Contact](https://info.mtmresearch.com/contact)

Open main navigation

Close main navigation

- [Blog](https://info.mtmresearch.com/blog)
- [Contact](https://info.mtmresearch.com/contact)
- [Sign-up](https://www.mtmresearch.com/sign-up)

[Sign-up](https://www.mtmresearch.com/sign-up)

 Oct 20, 2024 3:56:03 PM

# Biotech and Pharma best performers w/e 10/18

[Steve](https://info.mtmresearch.com/blog/author/steve)

Share: [facebook-f icon](http://www.facebook.com/share.php?u=https://info.mtmresearch.com/blog/biotech-and-pharma-best-performers-w/e-10/18) [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://info.mtmresearch.com/blog/biotech-and-pharma-best-performers-w/e-10/18) [Twitter icon](https://twitter.com/intent/tweet?url=https://info.mtmresearch.com/blog/biotech-and-pharma-best-performers-w/e-10/18) [pinterest-p icon](http://pinterest.com/pin/create/link/?url=https://info.mtmresearch.com/blog/biotech-and-pharma-best-performers-w/e-10/18) [envelope icon](mailto:?body=https://info.mtmresearch.com/blog/biotech-and-pharma-best-performers-w/e-10/18)

Biotech was +4.8% on the week and the best performing sector, beating the wider US market by 2.5%. Biotech was the strongest industry group +6.5% on the week with Pharma lagging slightly at +4.6%. Micro cap (sub $0.8bn) Biotech was +7.7% and led sector performance.

Biotech best performers on the week:

Tevogen Bio (TVGN) +353% to $1.72 after announcing aggressive future revenue expectations for its lead drug candidate

ProQR Therapeutics (PRQR) +134% to $4.33 benefitted from the positive news from Wave Life Sciences regarding RNA editing validation which helped lift similar stocks including PRGR

Frequency Therapeutics (KRRO) +107% to $80.04 another RNA editing stock that benefited from the news at Wave Life Sciences

BioVie (BIVI) +99% to $2.35 following announcing the allowance for a Japanese patent application. The shares are -93% ytd

Wave Life Sciences (WVE) +78% to $15.31 announced that Takeda would not exercise an option on a drug candidate but concurrently provided an update on a GSK partnered drug WVE006 that suggested the drug had successfully mRNA edited in human 1b/2a trials 

Aprea Therapeutics (APRE) +69% to $4.4 on the back of stronger trading volume over the week equivalent to 4.5x annualised daily average with Wednesday and Thursday 7.8x the annualised daily average

Longboard Pharma (LBPH) +52% to $59.21 following an agreed $60 / share bid from Lundbeck

MeiraGTx (MGTX) +44% to $6.16 following a positive update on its clinical bridging study for its Parkinson's candidate 

Lexeo (LXEO) +36% to $11.12 following strong trading volumes on Friday 4.5x normal daily levels

 

Pharma best performers on the week:

Amylyx Pharma (AMLX) +35% to $4.78 following positive news on a Phase 2 study treating Wolfram Syndrome

Jasper Therapeutics (JSPR) +34% to $20.04 following a positive update on their 1b/2a study to treat CIndU

Eyepoint Pharma (EYPT) +25% to $11.05. The company announced an employee option grant though this in itself does not seem to explain the share price strength.

Ocular Therapeutics (OCUL) +16% to $11.33. No new news but the shares have been very strong and are +389% over 1 yr and +117% over 6 months

Indivior (INDV) +15% to $8.56. The company announced details of a share buy back of 635k shares as part of the $100m plan. The shares at -56% ytd

Harrow Health (HROW) +13% to $57.48. The shares continue to run strongly and are +130% over 3 months

 

 

 

 

 

 

 

## Related posts

## [US equity markets stabilised Monday but 10 yr bond yields remains a concern](https://info.mtmresearch.com/blog/us-equity-markets-stabilised-yesterday-but-10-yr-bond-yields-remains-a-concern)

[Steve](https://info.mtmresearch.com/blog/author/steve) 

 Jan 14, 2025 7:25:58 AM

The market started 2025 with microcap and risk stocks in particular strongly outperforming the...

[Read more](https://info.mtmresearch.com/blog/us-equity-markets-stabilised-yesterday-but-10-yr-bond-yields-remains-a-concern)

## [Today is about nonfarm payroll.. tomorrow is about the Fed decision 9/18](https://info.mtmresearch.com/blog/today-is-about-nonfarm-payroll..-tomorrow-is-about-the-fed-decision-9/18)

[Steve](https://info.mtmresearch.com/blog/author/steve) 

 Sep 6, 2024 6:31:51 AM

The indices were fairly volatile again yesterday and all were in both positive and negative...

[Read more](https://info.mtmresearch.com/blog/today-is-about-nonfarm-payroll..-tomorrow-is-about-the-fed-decision-9/18)

## [China stimulus package pushes Basic Materials higher Tuesday](https://info.mtmresearch.com/blog/china-stimulus-package-pushes-basic-materials-higher)

[Steve](https://info.mtmresearch.com/blog/author/steve) 

 Sep 25, 2024 5:03:39 AM

The US Indices were all up on Tuesday with all market caps bands ahead. The VIX was up slightly to...

[Read more](https://info.mtmresearch.com/blog/china-stimulus-package-pushes-basic-materials-higher)

© MTM Data Research Ltd. Company Number 14145566. Registered in England and Wales.

enquiries. [contact@mtmresearch.com](mailto:contact@mtmresearch.com)

[linkedin-in icon](https://www.linkedin.com/company/mtm-data-research) [X Twitter icon](https://x.com/mtmdataresearch) [instagram icon](https://www.instagram.com/mtmdataresearch/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Steve",
    "url" : "https://info.mtmresearch.com/blog/author/steve"
  },
  "dateModified" : "2024-10-20T19:56:03.214Z",
  "datePublished" : "2024-10-20T19:56:03.000Z",
  "headline" : "Biotech and Pharma best performers w/e 10/18",
  "mainEntityOfPage" : {
    "@id" : "https://info.mtmresearch.com/blog/biotech-and-pharma-best-performers-w/e-10/18",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://info.mtmresearch.com/hubfs/logo-blue-1-svg%20(2).png"
    },
    "name" : "MTM Research"
  }
}
```